AI Article Synopsis
- 37 patients underwent chin augmentation using HTR-polymer implants, with 13 having mandibular retrognathia and 24 having normal occlusion.
- Three patients had micrognathia and juvenile rheumatoid arthritis.
- Follow-up for at least one year (up to five years) revealed highly predictable results and minimal side effects of the augmentation.
Article Abstract
A total of 37 patients have had chin augmentation procedures with HTR-polymer implants. Indications were mandibular retrognathia in connection with dentofacial deformities in 13 and the remaining 24 had a normal occlusion. Three patients with micrognathia also had juvenile rheumatoid arthritis. The patients have been followed for at least one year and in 17 cases up to five years both clinically and radiographically. Cephalometric measurements of the effects and stability of augmentation showed that chin augmentation has highly predictable results, and few side-effects.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/028443102753575194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bifocal refractive corneal inlay implantation to improve near vision in emmetropic presbyopic patients.
J Cataract Refract Surg
September 2015
From the Ophthalmology Department (Malandrini, Menabuoni, Catanese, Corsani, Fantozzi), Misericordia e Dolce Hospital, Prato, and the Ophthalmology Department (Martone, Tosi, Balestrazzi), University of Siena, Siena, Italy.
Purpose: To evaluate the safety and effectiveness of the Flexivue Microlens corneal inlay for the improvement of near vision in emmetropic presbyopic patients.
Setting: Ophthalmology Department, Misericordia e Dolce Hospital, Prato, Italy.
Design: Prospective interventional case series.
Fracture of a HTR-PMI cranioplastic implant after severe TBI.
Childs Nerv Syst
February 2015
Department of Neurosurgery, Virgen Macarena and Virgen del Rocío University Hospitals, Sevilla, Spain,
A 13-year-old girl with a large left fronto-parietal hard-tissue replacement patient-matched implant (HTR®-PMI) cranioplasty-since she suffered from a traumatic brain injury (TBI) 6 years ago-had a new severe TBI that detached and fractured the implant as well as caused a left subdural hematoma and a large frontal contusion. The hematoma and contusion were removed and the implant was substituted by a provisional titanium mesh. To the best of our knowledge, this is the first case reported about an HTR®-PMI fracture.
View Article and Find Full Text PDFFacial skeletal augmentation using custom facial implants.
Atlas Oral Maxillofac Surg Clin North Am
March 2012
Private Practice, New York Oral, Maxillofacial, and Implant Surgery, Scarsdale, NY 10583, USA.
Long-term follow-up of a supradescemetic keratoprosthesis in rabbits: an immunofluorescence study.
Graefes Arch Clin Exp Ophthalmol
February 2011
Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 1638 NW 10 Avenue, Miami, FL 33136, USA.
Objective: To evaluate the long-term clinical and immunohistological outcome of two different non-penetrating keratoprosthesis (KPro) implanted in non-injured rabbit corneas.
Materials And Methods: Three rabbits underwent implantation of a pHEMA-MMA(34) synthetic cornea in the supradescemetic space, and PMMA synthetic corneas in the supradescemetic space and within the central stroma. Animals were followed for at least 24 months before euthanasia.
Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells.
Tissue Eng Part A
August 2009
Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Placental growth factor (PlGF) combined with vascular endothelial growth factor (VEGF(164)) did not result in greater luciferase expression of a microencapsulated genetically transfected mouse fibroblast cell line (L929 cells) implanted subcutaneously in nominally syngeneic C3H/HeJ mice than in a control without growth factors. The intent had been to increase the maturity status of VEGF-generated vessels in the implant site by co-delivery of PlGF and thereby to effect an improvement in the persistence of luciferase expression, a marker of encapsulated cell viability. L929 cells were doubly transfected with luciferase and PlGF or luciferase and VEGF.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!